Tumor necrosis factor-α inhibitor-related autoimmune disorders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor necrosis factor-α inhibitor-related autoimmune disorders

Published:2023-07 Issue:7 Volume:22 Page:103332
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

De Stefano Ludovico,Pallavicini Francesca Bobbio,Mauric Eleonora,Piccin Veronica,Vismara Enrico Maria,Montecucco Carlomaurizio,Bugatti Serena

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference196 articles.

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update;Smolen;Ann. Rheum. Dis.,2023

2. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus;Fanouriakis;Ann. Rheum. Dis.,2019

3. Update of EULAR recommendations for the treatment of systemic sclerosis;Kowal-Bielecka;Ann. Rheum. Dis.,2017

4. Biologics-induced autoimmune diseases;Perez-Alvarez;Curr. Opin. Rheumatol.,2013

5. Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS registry);Pérez-De-Lis;Expert Opin. Drug Saf.,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Necrosis Alpha (TNF-α) Antagonists Used in Chronic Inflammatory Rheumatic Diseases: Risks and their Minimization Measures;Current Drug Safety;2024-11

2. A triterpenoid (corosolic acid) ameliorated AOM-mediated aberrant crypt foci in rats: modulation of Bax/PCNA, antioxidant and inflammatory mechanisms;Journal of Molecular Histology;2024-08-10

3. Tumor necrosis factor ALPHA Inhibitor Associated Köhlmeier–Degos Disease as a Novel Iatrogenic Paradigm That Underscores Excessive Type I Interferon in Its Pathogenesis;The American Journal of Dermatopathology;2024-06-14

4. EGFR inhibits TNF-α-mediated pathway by phosphorylating TNFR1 at tyrosine 360 and 401;Cell Death & Differentiation;2024-05-24

5. Deciphering the complex interplay of obesity, epithelial barrier dysfunction, and tight junction remodeling: Unraveling potential therapeutic avenues;Obesity Reviews;2024-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3